Correlation Between Equity Commonwealth and Bristol-Myers Squibb

Can any of the company-specific risk be diversified away by investing in both Equity Commonwealth and Bristol-Myers Squibb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equity Commonwealth and Bristol-Myers Squibb into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Equity Commonwealth and Bristol Myers Squibb, you can compare the effects of market volatilities on Equity Commonwealth and Bristol-Myers Squibb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equity Commonwealth with a short position of Bristol-Myers Squibb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equity Commonwealth and Bristol-Myers Squibb.

Diversification Opportunities for Equity Commonwealth and Bristol-Myers Squibb

-0.65

Correlation Coefficient

Equity Commonwealth  Bristol-Myers Squibb

Excellent diversification

The 3 months correlation between Equity and Bristol-Myers is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Equity Commonwealth and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Equity Commonwealth is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equity Commonwealth are associated (or correlated) with Bristol-Myers Squibb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Equity Commonwealth i.e., Equity Commonwealth and Bristol-Myers Squibb go up and down completely randomly.

Pair Corralation between Equity Commonwealth and Bristol-Myers Squibb

Considering the 90-day investment horizon Equity Commonwealth is expected to under-perform the Bristol-Myers Squibb. But the stock apears to be less risky and, when comparing its historical volatility, Equity Commonwealth is 2.23 times less risky than Bristol-Myers Squibb. The stock trades about -0.08 of its potential returns per unit of risk. The Bristol Myers Squibb is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  93,474  in Bristol Myers Squibb on December 26, 2024 and sell it today you would earn a total of  4,026  from holding Bristol Myers Squibb or generate 4.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	60.0%
Values	Daily Returns

Equity Commonwealth  vs.  Bristol Myers Squibb

Equity Commonwealth

Risk-Adjusted Performance

Very Weak

Over the last 90 days Equity Commonwealth has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Bristol Myers Squibb

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Equity Commonwealth and Bristol-Myers Squibb

The main advantage of trading using opposite Equity Commonwealth and Bristol-Myers Squibb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equity Commonwealth position performs unexpectedly, Bristol-Myers Squibb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol-Myers Squibb will offset losses from the drop in Bristol-Myers Squibb's long position.

The idea behind Equity Commonwealth and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.